Mitsubishi Tanabe's Internal Hemorrhoid Drug Launches In South Korea
This article was originally published in PharmAsia News
Executive Summary
Mitsubishi Tanabe Pharma announced June 10 that its internal hemorrhoid sclerotherapy agent Zione, which was jointly developed with Naha, Okinawa-based new drug development company Leqio Pharma, was launched in the South Korean market by Yuhan Corp, a Seoul-based Korean pharmaceutical company. (Click here for more - Japanese language ) "South Korean Pharmaceutical Company launched Internal Hemorrhoid Drug Developed By Mitsubishi Tanabe" - Jiji Press News (6/10/08)